This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Scott M. Whitcup: Innovator in Ocular Treatment
Introduction
Scott M. Whitcup is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of ocular treatment through his innovative research and development. His work primarily focuses on methods to block cell adhesion molecules, which has implications for treating various ocular conditions.
Latest Patents
Scott M. Whitcup holds a patent related to blocking cell adhesion molecules and treating animals with ocular conditions. The present invention pertains to a method of blocking cell adhesion molecules using monoclonal antibodies or synthesized substances. This patent represents a significant advancement in the treatment of ocular diseases.
Career Highlights
Whitcup is associated with the United States of America as represented by the Department of Health. His role in this esteemed organization underscores his commitment to advancing health care and medical research. His innovative approach has the potential to improve treatment outcomes for patients suffering from ocular issues.
Collaborations
Some of his notable coworkers include Chi-Chao Chan and Robert B. Nussenblatt. Their collaboration has likely contributed to the success of his research and the development of his patent.
Conclusion
Scott M. Whitcup's work in blocking cell adhesion molecules showcases his dedication to improving ocular health. His innovative methods and collaborations highlight the importance of research in advancing medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile